Timing and number of minor infections as risk factors for childhood arterial ischemic stroke
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received January 9, 2014
- Accepted in final form May 14, 2014
- First Published August 20, 2014.
Article Versions
- Previous version (August 20, 2014 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Nancy K. Hills, PhD,
- Stephen Sidney, MD, MPH and
- Heather J. Fullerton, MD, MAS
- Nancy K. Hills, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Thrasher Research Foundation RAS-A116619 2/1/11-1/31/13 (no-cost extension until 1/31/14) Stimulants and Childhood Stroke (StaCS) This is a case-control study nested within the cohort of the 2.5 million children enrolled in KPMCP from 1993-2007 with the goal of determining whether ADHD medications increase the risk of childhood arterial ischemic stroke.Role: PI
NONE
NONE
NONE
NONE
NONE
NONE
- Stephen Sidney, MD, MPH and
All Non-Profit Entities: 1.External Scientific Advisory Cmtee for MESA Air Study 2.National Forum for Heart Disease and Stroke Prevention 3.GRADE DSM 4.NHLBI CVD Surveillance Workgroup
NONE
All Non-Profit Entries: 1.External Scientific Advisory Cmtee for MESA Air Study 2.National Forum for Heart Disease and Stroke Prevention 3.FDA Guest Speaker Review Committee Dec 2011 4.GRADE DSMB 5.NHLBI CVD Surveillance Workgroup
NONE
NONE
NONE
The Permanente Medical Group
NONE
NONE
NONE
NONE
NONE
Funded as principal investigator on NHLBI Contract N01 HC-48050 12/30/83-6/30/18; Funded as principal investigator on NINDS U54NS081760 10/1/12-9/30/17; Funded as co-investigator on NINDS U54NS081760 10/1/12-9/30/17; Funded as co-investigator on NIDDK/ GHRI R01DK092317 10/1/12-9/30/16; Funded as co-investigator on AHA/UCSF 12 EIA 9130050 A119064 1/1/12-12/31/14
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Heather J. Fullerton, MD, MAS
I serve on a DSMB for the NIH for clinical trials related to sickle cell disease and stroke.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
R01 NS062820HJ (PI) NIH/NINDS Vascular Effects of Infection in Pediatric Stroke (VIPS) 08/05/2009 - 07/31/2014; R01 NS062820-02S1(PI) NIH/NINDS Global Health Supplement to VIPS 08/01/2010 - 07/31/2011; K02 NS053883(PI) NIH/NINDS Independent Scientist Award The Role of Infection in Childhood Stroke 06/01/2006 - 08/31/2011 R01 HL096789-01RJ (Co-investigator) NIH/HSOD Prevention of Stroke after STOP (POST-STOP) 07/01/2009 - 06/30/2014
NONE
American Heart Association Established Investigator Award
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (N.K.H., H.J.F.), Epidemiology and Biostatistics (N.K.H.), and Pediatrics (H.J.F.), University of California, San Francisco; and the Division of Research (S.S.), Kaiser Permanente Northern California, Oakland.
- Correspondence to Dr. Fullerton: FullertonH{at}neuropeds.ucsf.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.